Table 4.
Findings of D4R expression in LYM of patients with SCZ.
| Reference | Study | n | Sample | Methodology | Clinical features | Findings |
|---|---|---|---|---|---|---|
| Ilani et al., 2004 | Healthy controls | 11 | PBLs | RT-PCR | ND | No differences in D4R mRNA |
| SCZ patients | 14 | |||||
| Rodrigues et al., 2005 | Healthy controls | 45 | PBLs | Flow-cytometry | BPRS | No differences in D4R protein levels |
| SCZ patients | 45 | Significant inverse correlation (BPRS hebephrenic dimension score vs D4R) | ||||
| Boneberg et al., 2006 | Healthy controls | 10 | Leukocyte population PBMCs |
qRT-PCR | ND | Decreased D4R mRNA in T cells |
| SCZ patients | 10 | |||||
| Kawano et al., 2011 | Healthy controls | 12 | PBLs | qRT-PCR | PANSS, BACS-J, Treatment, Dose, Duration of illness | No differences in D4R mRNA |
| SCZ patients | 11 | D4R mRNA positively correlated with working memory scales | ||||
| Brito-Melo et al., 2012 | Healthy controls SCZ patients |
20 40 |
LYM (CD4, CD8) | Flow-cytometry | CGIS, BPRS, PANSS, AIMS, Duration of illness and hospitalization,Dose of antipsychotic | Increased percentages of CD4+D4R+ and CD8+D4R+ cells |
| AIMS inversely related to CD4+D4R+ cells | ||||||
| Ahmadian et al., 2014 | Healthy controls | 20 | PBLs | RT-PCR | ND | D4R expressed in all groups but no differences in mRNA |
| Drug-naïve SCZ patients | 5 | |||||
| Drug-free SCZ patients (» 3 months) | 15 | |||||
| Drug-medicated SCZ patients (» 3 years) | 22 | |||||
| Fernandez-Egea et al., 2016 | Healthy controls | 18 | LYM | qRT-PCR | BMI, Smoking, BACS, CGIS | No differences in D4R mRNA |
| Chronic SCZ patients | 18 | D4R mRNA positively correlated with working memory scales |
Abbreviations: Brief Psychiatric Rating Scale (BPRS), Positive and Negative Syndrome Scale (PANSS) for Schizophrenia, Brief Assessment of Cognition in Schizophrenia (BACS), Clinical Global Impression Scale (CGIS), Abnormal Involuntary Movement Scale (AIMS), Body mass index (BMI). No Data (ND).